Patients with low CALLY scores were significantly more likely to have elevated CRP (p < 0.001), lower albumin (p < 0.001), reduced lymphocyte counts (p < 0.001), and higher tumor markers (CEA and CA19-9, both p < 0.001 and p = 0.001, respectively). This evidence concerns the gene ALB and neoplasm.